China — Fishery/Seafood Products — Squid-Octopus

← back to leaderboard

China received 4 FDA import refusals in Squid-Octopus, part of Fishery/Seafood Products between 2022-Q4 and 2025-Q3. Volume is roughly flat year-on-year. The most-cited issues are added bulk, filthy, and cyclamate. No trade baseline is published for this commodity from China, so no per-$1B rate is shown here.

Of these, 4 were hazard refusals and 0 were paperwork refusals.

Exporting from China? Get an email when shipments from China are refused at the US border — before your buyers ask.

Quarterly rejections, last 12 quarters

0 2022-Q4 2022-Q4: 0 0 2023-Q1 2023-Q1: 0 1 2023-Q2 2023-Q2: 1 1 2023-Q3 2023-Q3: 1 1 2023-Q4 2023-Q4: 1 0 2024-Q1 2024-Q1: 0 0 2024-Q2 2024-Q2: 0 0 2024-Q3 2024-Q3: 0 0 2024-Q4 2024-Q4: 0 0 2025-Q1 2025-Q1: 0 0 2025-Q2 2025-Q2: 0 1 2025-Q3 2025-Q3: 1

Recent rejections